Confirm patient consent, verify baseline coagulation profile (INR/platelets), ensure 6-hour fasting from solids and liquids, and record baseline vital signs. Prophylactic antibiotics may be administered if indicated based on institutional guidelines. Confirm medication history, specifically anticoagulants, for appropriate bridging or cessation.
Monitor vital signs and observe for acute complications such as hypotension, fever, or pain for 1-2 hours in the recovery area. Patient may resume clear liquids once sedation wears off. Discharge instructions: monitor for severe abdominal pain, fever, or bloody stools; avoid heavy lifting for 24 hours. Follow-up clinic visit scheduled in 1-2 weeks.
Comprehensive Clinical Guide: Endoscopic Ultrasound-Guided Celiac Plexus Block (EUS-CPB) with Steroids
1. Introduction & Clinical Overview
Endoscopic Ultrasound-guided Celiac Plexus Block (EUS-CPB) represents a sophisticated, minimally invasive interventional technique designed to alleviate intractable abdominal pain associated with pancreatic malignancy and chronic pancreatitis. By utilizing real-time endosonography, clinicians can precisely target the celiac plexus—a complex network of nerves located behind the stomach near the aorta—to deliver therapeutic agents.
While traditional EUS-CPB often utilizes a combination of local anesthetics and neurolytic agents (such as absolute ethanol), the inclusion of corticosteroids (typically triamcinolone or methylprednisolone) has emerged as a specialized strategy. The addition of steroids is primarily aimed at reducing local inflammation, minimizing post-procedural flare, and potentially prolonging the duration of analgesia in patients with inflammatory-mediated pain pathways.
2. Technical Specifications & Mechanisms of Action
The celiac plexus is the largest autonomic plexus in the abdomen. It receives sympathetic input from the greater, lesser, and least splanchnic nerves and parasympathetic input from the vagus nerves.
The Mechanism of Action
- Neural Blockade: The anesthetic component provides immediate, albeit transient, interruption of pain signaling.
- Anti-Inflammatory Modulation: The inclusion of corticosteroids targets the perineural inflammatory environment. In chronic pancreatitis, the pain is often driven by perineural inflammation and infiltration. Steroids act by inhibiting the release of proinflammatory cytokines, stabilizing lysosomal membranes, and decreasing capillary permeability in the targeted plexus.
- Synergistic Effect: Unlike pure neurolysis (which destroys nerve tissue), the use of steroids and anesthetics functions as a "blockade," potentially offering a safer profile for patients who may not tolerate the systemic side effects of neurolytic agents.
Procedural Technical Requirements
| Component | Specification |
|---|---|
| Endoscope | Linear array echoendoscope |
| Needle | 19G or 22G fine-needle aspiration (FNA) needle |
| Agent A | 0.25% - 0.5% Bupivacaine or Lidocaine |
| Agent B | Triamcinolone (40-80mg) or Methylprednisolone |
| Guidance | Real-time EUS visualization of the aorta and celiac trunk |
3. Clinical Indications & Patient Selection
EUS-CPB with steroids is not a first-line therapy for all abdominal pain. It is strictly indicated for visceral pain originating from the upper abdominal organs.
Primary Indications
- Chronic Pancreatitis: Specifically when pain is refractory to conventional oral analgesics, including opioids.
- Pancreatic Cancer (Palliative): Used to reduce opioid requirements and improve quality of life.
- Post-surgical Abdominal Pain: Occasionally utilized in patients with chronic pain following pancreatic resection.
- Contraindication to Neurolysis: In patients where the destruction of the celiac plexus (neurolysis) is deemed too risky or unnecessary, the steroid-anesthetic block serves as a diagnostic or therapeutic bridge.
Patient Selection Criteria
- Pain clearly localized to the epigastrium.
- Documented failure of optimized medical management (WHO analgesic ladder).
- Absence of severe coagulopathy (INR < 1.5, Platelets > 50,000).
- Informed consent regarding the palliative nature of the procedure.
4. Pre-Operative Preparation
Success in interventional endoscopy is predicated on meticulous preparation.
- Laboratory Assessment: CBC, PT/INR, PTT, and metabolic panel.
- Anticoagulation Management: Hold antiplatelet/anticoagulant therapy per ASGE guidelines (e.g., Clopidogrel 5-7 days; Warfarin 5 days).
- Antibiotic Prophylaxis: While controversial for standard CPB, many institutions mandate prophylactic antibiotics (e.g., Cefazolin or Ciprofloxacin) to prevent infection of the retroperitoneal space.
- NPO Status: Minimum of 8 hours for solids; 2 hours for clear liquids.
- Anesthesia: Usually performed under conscious sedation or monitored anesthesia care (MAC) with propofol.
5. Detailed Procedural Steps
The procedure is performed in a dedicated endoscopy suite with fluoroscopic capabilities if needed.
- Endoscopic Access: The linear echoendoscope is advanced into the stomach.
- Anatomic Identification: The endoscope is positioned at the level of the celiac trunk. The celiac artery is identified as it branches off the aorta.
- Targeting: The celiac plexus is visualized as a hypoechoic region surrounding the origin of the celiac artery.
- Needle Insertion: The needle is advanced through the posterior wall of the stomach into the retroperitoneum.
- Aspiration: Crucial step—aspiration is performed to ensure the needle is not in a vascular structure (aorta or celiac artery).
- Injection: The anesthetic/steroid mixture is injected in a "fan" pattern to ensure broad distribution around the nerve plexus.
- Withdrawal: The needle is retracted, and the stomach wall is inspected for immediate bleeding.
6. Post-Operative Recovery Protocol
Patients are typically observed for 2–4 hours post-procedure.
- Vitals Monitoring: Monitor for signs of hypotension or tachycardia, which may indicate a systemic reaction to the anesthetic or a vasovagal response.
- Dietary Advancement: Liquids may be initiated once sedation wears off; solids are introduced as tolerated.
- Pain Monitoring: A baseline pain score is recorded. Patients often report an initial "flare" before the stabilization of the steroid effect.
- Discharge Instructions:
- Avoid heavy lifting for 24 hours.
- Continue routine oral pain medications (do not stop abruptly).
- Contact the clinic if fever, chills, or severe, unremitting abdominal pain occurs.
7. Potential Complications & Risks
While EUS-CPB is generally safe, the proximity to major vascular structures and the pancreas necessitates caution.
| Complication | Incidence | Management |
|---|---|---|
| Transient Diarrhea | Common (40-60%) | Antidiarrheal agents (Loperamide) |
| Hypotension | Low | IV fluids, Trendelenburg position |
| Abdominal Pain Flare | Moderate | Oral analgesics |
| Procedural Bleeding | Rare | Endoscopic hemostasis/observation |
| Retroperitoneal Infection | Very Rare | Antibiotics/Drainage |
Contraindications:
* Uncorrected coagulopathy.
* Active infection at the puncture site.
* Ascites (increased risk of peritonitis).
* Anatomical distortion preventing safe needle access.
8. Alternative Treatments
When EUS-CPB with steroids is insufficient, clinicians may consider:
* EUS-CP Neurolysis: Using 98% ethanol to chemically destroy the nerve fibers. More potent but associated with higher rates of diarrhea and temporary pain flares.
* Pharmacotherapy: Escalation to potent opioids, gabapentinoids, or SSRIs for neuropathic pain.
* Radiotherapy: If the pain is secondary to tumor bulk, palliative radiation may reduce nerve compression.
* Surgical Splanchnicectomy: A major surgical procedure for refractory chronic pancreatitis pain.
9. Frequently Asked Questions (FAQ)
1. Is EUS-CPB with steroids a permanent cure?
No. It is a palliative intervention. The effect typically lasts between 3 to 6 months.
2. Why add steroids to the block?
Steroids reduce the inflammatory reaction around the nerves, which can provide a more sustained period of relief compared to anesthesia alone, without the permanent nerve destruction of neurolysis.
3. Does the procedure require general anesthesia?
Usually, it is performed under MAC (Monitored Anesthesia Care) using propofol, allowing the patient to breathe spontaneously while remaining deeply sedated.
4. How long does the procedure take?
The actual intervention typically takes between 20 to 45 minutes.
5. Will I be able to go home the same day?
Yes, this is an outpatient procedure. Patients are usually discharged within a few hours.
6. What are the most common side effects?
The most frequent side effect is transient diarrhea, occurring due to the interruption of sympathetic nerve fibers that regulate bowel motility.
7. Can the procedure be repeated?
Yes, if the initial block provides significant relief, it can be repeated if the pain recurs.
8. Is there a risk of hitting the aorta?
While the aorta is near the target, real-time EUS and color Doppler imaging are used to map and avoid blood vessels, making this risk extremely low.
9. When will I feel the effects of the block?
The anesthetic provides immediate relief, but the anti-inflammatory effect of the steroids may take 48–72 hours to reach peak efficacy.
10. What if I am on blood thinners?
You must coordinate with your cardiologist or primary care physician to safely bridge or pause these medications prior to the procedure to minimize the risk of bleeding.
10. Conclusion
EUS-Celiac Plexus Block with steroids is a highly effective, targeted intervention for patients suffering from the debilitating pain of pancreatic disease. By leveraging the precision of endoscopic ultrasound, specialists can provide meaningful relief with a favorable safety profile. Successful outcomes depend on rigorous patient selection, meticulous technical execution, and a clear understanding of the palliative goals of the therapy. As interventional gastroenterology continues to evolve, the refinement of these blocks remains a cornerstone of multidisciplinary pain management.